|
Market Closed -
London S.E.
12:35:01 2026-10-26 EDT
|
5-day change | 1st Jan Change | ||
| 0.2150 GBX | -4.44% |
|
-8.51% | -70.34% |
| 10-22 | Wag Payment investor to offload remaining shares | AN |
| 10-22 | Verici Dx to Supply Tests for Kidney Transplant Therapy Trial | MT |
Evolution of the Average Target: Verici Dx plc
Evolution of the Target Price: Verici Dx plc
Changes in Analyst Recommendations: Verici Dx plc
5a41166f46209aed84ea74c3d415b.XO_mV4IwgHr52mMrm5utdcrwJCGpeVseZm6RhaJ8Qts.Dp2CLuVD1UiLmAIb1trFO_medmL9IxdoEC_6_Y8OIY0Ji6UttmnULo-ZLg~7071d9f422892b6b1da16ca760059244
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
| - | - | +1,188.89% | ||||
| +14.29% | ||||||
| +18.06% | ||||||
| +9.65% | ||||||
| +19.16% | ||||||
| +11.51% | ||||||
| +17.34% | ||||||
| -1.68% | ||||||
| +24.56% | ||||||
| +29.2% | ||||||
| Average | +133.10% | |||||
| Weighted average by Cap. | +14.89% |


Analysts' Consensus
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.002150GBP
Average target price
0.0290GBP
Spread / Average Target
+1,248.84%
High Price Target
0.0290GBP
Spread / Highest target
+1,248.84%
Low Price Target
0.0290GBP
Spread / Lowest Target
+1,248.84%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- VRCI Stock
- Consensus Verici Dx plc
Select your edition
All financial news and data tailored to specific country editions
















